Hexagon Nutrition Ltd
- Market Cap ₹ 0.00 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 0.00
- Book Value ₹
- Dividend Yield %
- ROCE 15.3 %
- ROE 15.6 %
- Face Value ₹ 1.00
Pros
Cons
- Company has a low return on equity of 10.2% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.5.36 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 99 | 86 | 107 | 114 | 132 | |
| 88 | 79 | 94 | 115 | 119 | |
| Operating Profit | 10 | 7 | 13 | -1 | 13 |
| OPM % | 11% | 9% | 12% | -1% | 10% |
| 1 | 3 | 2 | 2 | 5 | |
| Interest | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 2 | 2 | 3 | 3 |
| Profit before tax | 8 | 7 | 13 | -3 | 14 |
| Tax % | 7% | 24% | 29% | 18% | 25% |
| 7 | 6 | 9 | -3 | 10 | |
| EPS in Rs | 24.63 | 18.97 | 29.77 | -10.33 | 34.87 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 31% |
| TTM: | 1338% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 10% |
| Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 |
| Reserves | 35 | 37 | 56 | 51 | 61 |
| 26 | 25 | 22 | 28 | 40 | |
| 24 | 21 | 26 | 36 | 28 | |
| Total Liabilities | 96 | 94 | 116 | 126 | 141 |
| 21 | 20 | 20 | 22 | 25 | |
| CWIP | 0 | 0 | 2 | 1 | 2 |
| Investments | 12 | 16 | 20 | 16 | 8 |
| 62 | 58 | 74 | 86 | 107 | |
| Total Assets | 96 | 94 | 116 | 126 | 141 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Net Cash Flow | |||||
| Free Cash Flow | |||||
| CFO/OP |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 50 | 57 | 52 | 76 | 67 |
| Inventory Days | 128 | 149 | 192 | 150 | 146 |
| Days Payable | 108 | 95 | 108 | 152 | 80 |
| Cash Conversion Cycle | 71 | 110 | 136 | 74 | 132 |
| Working Capital Days | 89 | 58 | 76 | 65 | 1 |
| ROCE % | 10% | 15% | 2% | 15% |
Documents
Annual reports
No data available.